Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity

Chung, R., McKiernan, J., Arpaia, N., Marabelle, A., & Rouanne, M. (2023). Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity. European Journal of Cancer, 187, 58–64. https://doi.org/10.1016/j.ejca.2023.03.037
Authors:
Rainjade Chung
James M. McKiernan
Nicholas Arpaia
Aurélien Marabelle
Mathieu Rouanne
Affiliated Authors:
Rainjade Chung
James M. McKiernan
Nicholas Arpaia
Mathieu Rouanne
Columbia Affiliation:
Subjects:
BCG Vaccine (MeSH)
Urinary Bladder Neoplasms (MeSH)
Diagnosis and Treatment of Bladder Cancer (OpenAlex Topic)
Clinical and Pathological Aspects of Urachal Carcinoma (OpenAlex Topic)
Cancer Immunotherapy (OpenAlex Topic)
Author Keywords:
bladder cancer
drug development
immunotherapy
mucosal immunity
elink
Publication Type:
Article
Unique ID:
10.1016/j.ejca.2023.03.037
PMID:
37116288
DOI:
10.1016/j.ejca.2023.03.037
Journal:
European Journal of Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: